nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP2D6—Vinorelbine—ovarian cancer	0.0941	0.255	CbGbCtD
Bisoprolol—CYP3A4—Topotecan—ovarian cancer	0.085	0.23	CbGbCtD
Bisoprolol—CYP3A4—Vinorelbine—ovarian cancer	0.0599	0.162	CbGbCtD
Bisoprolol—CYP3A4—Paclitaxel—ovarian cancer	0.0421	0.114	CbGbCtD
Bisoprolol—CYP2D6—Doxorubicin—ovarian cancer	0.0356	0.0964	CbGbCtD
Bisoprolol—CYP3A4—Docetaxel—ovarian cancer	0.0304	0.0822	CbGbCtD
Bisoprolol—CYP3A4—Doxorubicin—ovarian cancer	0.0227	0.0613	CbGbCtD
Bisoprolol—Atenolol—ABCB1—ovarian cancer	0.000792	0.323	CrCbGaD
Bisoprolol—Acebutolol—ABCB1—ovarian cancer	0.000731	0.298	CrCbGaD
Bisoprolol—Metoprolol—ABCB1—ovarian cancer	0.000617	0.252	CrCbGaD
Bisoprolol—Dizziness—Vinorelbine—ovarian cancer	0.000516	0.000822	CcSEcCtD
Bisoprolol—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000516	0.000822	CcSEcCtD
Bisoprolol—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000516	0.000822	CcSEcCtD
Bisoprolol—Nervous system disorder—Paclitaxel—ovarian cancer	0.000515	0.00082	CcSEcCtD
Bisoprolol—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000514	0.000819	CcSEcCtD
Bisoprolol—Tachycardia—Paclitaxel—ovarian cancer	0.000512	0.000816	CcSEcCtD
Bisoprolol—Breast disorder—Doxorubicin—ovarian cancer	0.000511	0.000813	CcSEcCtD
Bisoprolol—Skin disorder—Paclitaxel—ovarian cancer	0.00051	0.000812	CcSEcCtD
Bisoprolol—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000509	0.00081	CcSEcCtD
Bisoprolol—Bronchitis—Epirubicin—ovarian cancer	0.000508	0.000808	CcSEcCtD
Bisoprolol—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000507	0.000808	CcSEcCtD
Bisoprolol—Gastritis—Doxorubicin—ovarian cancer	0.0005	0.000796	CcSEcCtD
Bisoprolol—Muscular weakness—Doxorubicin—ovarian cancer	0.000498	0.000794	CcSEcCtD
Bisoprolol—Vomiting—Vinorelbine—ovarian cancer	0.000496	0.00079	CcSEcCtD
Bisoprolol—Rash—Vinorelbine—ovarian cancer	0.000492	0.000784	CcSEcCtD
Bisoprolol—Dermatitis—Vinorelbine—ovarian cancer	0.000492	0.000783	CcSEcCtD
Bisoprolol—Hypotension—Paclitaxel—ovarian cancer	0.000491	0.000781	CcSEcCtD
Bisoprolol—Headache—Vinorelbine—ovarian cancer	0.000489	0.000779	CcSEcCtD
Bisoprolol—Syncope—Docetaxel—ovarian cancer	0.000489	0.000779	CcSEcCtD
Bisoprolol—Asthma—Doxorubicin—ovarian cancer	0.000488	0.000778	CcSEcCtD
Bisoprolol—Palpitations—Docetaxel—ovarian cancer	0.000482	0.000767	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000482	0.000767	CcSEcCtD
Bisoprolol—Weight increased—Epirubicin—ovarian cancer	0.00048	0.000765	CcSEcCtD
Bisoprolol—Loss of consciousness—Docetaxel—ovarian cancer	0.000479	0.000763	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000478	0.000762	CcSEcCtD
Bisoprolol—Cough—Docetaxel—ovarian cancer	0.000476	0.000758	CcSEcCtD
Bisoprolol—Insomnia—Paclitaxel—ovarian cancer	0.000475	0.000756	CcSEcCtD
Bisoprolol—Pneumonia—Epirubicin—ovarian cancer	0.000473	0.000754	CcSEcCtD
Bisoprolol—Paraesthesia—Paclitaxel—ovarian cancer	0.000471	0.000751	CcSEcCtD
Bisoprolol—Drowsiness—Epirubicin—ovarian cancer	0.000471	0.000749	CcSEcCtD
Bisoprolol—Bronchitis—Doxorubicin—ovarian cancer	0.00047	0.000748	CcSEcCtD
Bisoprolol—Dyspnoea—Paclitaxel—ovarian cancer	0.000468	0.000745	CcSEcCtD
Bisoprolol—Somnolence—Paclitaxel—ovarian cancer	0.000467	0.000743	CcSEcCtD
Bisoprolol—Arthralgia—Docetaxel—ovarian cancer	0.000464	0.000739	CcSEcCtD
Bisoprolol—Chest pain—Docetaxel—ovarian cancer	0.000464	0.000739	CcSEcCtD
Bisoprolol—Myalgia—Docetaxel—ovarian cancer	0.000464	0.000739	CcSEcCtD
Bisoprolol—Nausea—Vinorelbine—ovarian cancer	0.000464	0.000738	CcSEcCtD
Bisoprolol—Dyspepsia—Paclitaxel—ovarian cancer	0.000462	0.000736	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000461	0.000734	CcSEcCtD
Bisoprolol—Conjunctivitis—Epirubicin—ovarian cancer	0.000457	0.000728	CcSEcCtD
Bisoprolol—Urinary tract infection—Epirubicin—ovarian cancer	0.000457	0.000728	CcSEcCtD
Bisoprolol—Dry mouth—Docetaxel—ovarian cancer	0.000454	0.000723	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000453	0.000722	CcSEcCtD
Bisoprolol—Fatigue—Paclitaxel—ovarian cancer	0.000453	0.000721	CcSEcCtD
Bisoprolol—Sweating—Epirubicin—ovarian cancer	0.000451	0.000719	CcSEcCtD
Bisoprolol—Pain—Paclitaxel—ovarian cancer	0.000449	0.000715	CcSEcCtD
Bisoprolol—Constipation—Paclitaxel—ovarian cancer	0.000449	0.000715	CcSEcCtD
Bisoprolol—Confusional state—Docetaxel—ovarian cancer	0.000449	0.000715	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000446	0.00071	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000445	0.000709	CcSEcCtD
Bisoprolol—Oedema—Docetaxel—ovarian cancer	0.000445	0.000709	CcSEcCtD
Bisoprolol—Weight increased—Doxorubicin—ovarian cancer	0.000444	0.000708	CcSEcCtD
Bisoprolol—Infection—Docetaxel—ovarian cancer	0.000442	0.000704	CcSEcCtD
Bisoprolol—Sinusitis—Epirubicin—ovarian cancer	0.000441	0.000703	CcSEcCtD
Bisoprolol—Agranulocytosis—Epirubicin—ovarian cancer	0.000439	0.000699	CcSEcCtD
Bisoprolol—Pneumonia—Doxorubicin—ovarian cancer	0.000438	0.000697	CcSEcCtD
Bisoprolol—Shock—Docetaxel—ovarian cancer	0.000438	0.000697	CcSEcCtD
Bisoprolol—Nervous system disorder—Docetaxel—ovarian cancer	0.000436	0.000695	CcSEcCtD
Bisoprolol—Thrombocytopenia—Docetaxel—ovarian cancer	0.000436	0.000694	CcSEcCtD
Bisoprolol—Drowsiness—Doxorubicin—ovarian cancer	0.000435	0.000693	CcSEcCtD
Bisoprolol—Tachycardia—Docetaxel—ovarian cancer	0.000434	0.000692	CcSEcCtD
Bisoprolol—Feeling abnormal—Paclitaxel—ovarian cancer	0.000433	0.000689	CcSEcCtD
Bisoprolol—Skin disorder—Docetaxel—ovarian cancer	0.000432	0.000688	CcSEcCtD
Bisoprolol—Bradycardia—Epirubicin—ovarian cancer	0.00043	0.000685	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000429	0.000684	CcSEcCtD
Bisoprolol—Rhinitis—Epirubicin—ovarian cancer	0.000423	0.000675	CcSEcCtD
Bisoprolol—Urinary tract infection—Doxorubicin—ovarian cancer	0.000423	0.000674	CcSEcCtD
Bisoprolol—Conjunctivitis—Doxorubicin—ovarian cancer	0.000423	0.000674	CcSEcCtD
Bisoprolol—Hepatitis—Epirubicin—ovarian cancer	0.000422	0.000673	CcSEcCtD
Bisoprolol—Hypoaesthesia—Epirubicin—ovarian cancer	0.00042	0.000669	CcSEcCtD
Bisoprolol—Pharyngitis—Epirubicin—ovarian cancer	0.000419	0.000668	CcSEcCtD
Bisoprolol—Sweating—Doxorubicin—ovarian cancer	0.000417	0.000665	CcSEcCtD
Bisoprolol—Urticaria—Paclitaxel—ovarian cancer	0.000417	0.000664	CcSEcCtD
Bisoprolol—Oedema peripheral—Epirubicin—ovarian cancer	0.000416	0.000663	CcSEcCtD
Bisoprolol—Hypotension—Docetaxel—ovarian cancer	0.000416	0.000662	CcSEcCtD
Bisoprolol—Connective tissue disorder—Epirubicin—ovarian cancer	0.000415	0.000661	CcSEcCtD
Bisoprolol—Abdominal pain—Paclitaxel—ovarian cancer	0.000415	0.000661	CcSEcCtD
Bisoprolol—Body temperature increased—Paclitaxel—ovarian cancer	0.000415	0.000661	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000412	0.000656	CcSEcCtD
Bisoprolol—Sinusitis—Doxorubicin—ovarian cancer	0.000408	0.000651	CcSEcCtD
Bisoprolol—Visual impairment—Epirubicin—ovarian cancer	0.000407	0.000648	CcSEcCtD
Bisoprolol—Agranulocytosis—Doxorubicin—ovarian cancer	0.000406	0.000647	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000405	0.000646	CcSEcCtD
Bisoprolol—Insomnia—Docetaxel—ovarian cancer	0.000402	0.000641	CcSEcCtD
Bisoprolol—Paraesthesia—Docetaxel—ovarian cancer	0.0004	0.000636	CcSEcCtD
Bisoprolol—Bradycardia—Doxorubicin—ovarian cancer	0.000398	0.000634	CcSEcCtD
Bisoprolol—Dyspnoea—Docetaxel—ovarian cancer	0.000397	0.000632	CcSEcCtD
Bisoprolol—Somnolence—Docetaxel—ovarian cancer	0.000396	0.00063	CcSEcCtD
Bisoprolol—Eye disorder—Epirubicin—ovarian cancer	0.000395	0.000629	CcSEcCtD
Bisoprolol—Tinnitus—Epirubicin—ovarian cancer	0.000394	0.000627	CcSEcCtD
Bisoprolol—Cardiac disorder—Epirubicin—ovarian cancer	0.000392	0.000624	CcSEcCtD
Bisoprolol—Flushing—Epirubicin—ovarian cancer	0.000392	0.000624	CcSEcCtD
Bisoprolol—Rhinitis—Doxorubicin—ovarian cancer	0.000392	0.000624	CcSEcCtD
Bisoprolol—Dyspepsia—Docetaxel—ovarian cancer	0.000392	0.000624	CcSEcCtD
Bisoprolol—Hepatitis—Doxorubicin—ovarian cancer	0.000391	0.000623	CcSEcCtD
Bisoprolol—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000389	0.000619	CcSEcCtD
Bisoprolol—Pharyngitis—Doxorubicin—ovarian cancer	0.000388	0.000618	CcSEcCtD
Bisoprolol—Hypersensitivity—Paclitaxel—ovarian cancer	0.000387	0.000616	CcSEcCtD
Bisoprolol—Oedema peripheral—Doxorubicin—ovarian cancer	0.000385	0.000613	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000384	0.000612	CcSEcCtD
Bisoprolol—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000384	0.000612	CcSEcCtD
Bisoprolol—Fatigue—Docetaxel—ovarian cancer	0.000384	0.000611	CcSEcCtD
Bisoprolol—Angiopathy—Epirubicin—ovarian cancer	0.000383	0.00061	CcSEcCtD
Bisoprolol—Mediastinal disorder—Epirubicin—ovarian cancer	0.000381	0.000606	CcSEcCtD
Bisoprolol—Pain—Docetaxel—ovarian cancer	0.00038	0.000606	CcSEcCtD
Bisoprolol—Constipation—Docetaxel—ovarian cancer	0.00038	0.000606	CcSEcCtD
Bisoprolol—Arrhythmia—Epirubicin—ovarian cancer	0.000377	0.000601	CcSEcCtD
Bisoprolol—Visual impairment—Doxorubicin—ovarian cancer	0.000377	0.0006	CcSEcCtD
Bisoprolol—Asthenia—Paclitaxel—ovarian cancer	0.000377	0.0006	CcSEcCtD
Bisoprolol—Alopecia—Epirubicin—ovarian cancer	0.000373	0.000595	CcSEcCtD
Bisoprolol—Pruritus—Paclitaxel—ovarian cancer	0.000371	0.000592	CcSEcCtD
Bisoprolol—Mental disorder—Epirubicin—ovarian cancer	0.00037	0.000589	CcSEcCtD
Bisoprolol—Erythema—Epirubicin—ovarian cancer	0.000368	0.000586	CcSEcCtD
Bisoprolol—Feeling abnormal—Docetaxel—ovarian cancer	0.000367	0.000584	CcSEcCtD
Bisoprolol—Eye disorder—Doxorubicin—ovarian cancer	0.000365	0.000582	CcSEcCtD
Bisoprolol—Tinnitus—Doxorubicin—ovarian cancer	0.000364	0.00058	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000364	0.000579	CcSEcCtD
Bisoprolol—Flushing—Doxorubicin—ovarian cancer	0.000363	0.000578	CcSEcCtD
Bisoprolol—Cardiac disorder—Doxorubicin—ovarian cancer	0.000363	0.000578	CcSEcCtD
Bisoprolol—Dysgeusia—Epirubicin—ovarian cancer	0.00036	0.000574	CcSEcCtD
Bisoprolol—Diarrhoea—Paclitaxel—ovarian cancer	0.000359	0.000572	CcSEcCtD
Bisoprolol—Back pain—Epirubicin—ovarian cancer	0.000356	0.000567	CcSEcCtD
Bisoprolol—Angiopathy—Doxorubicin—ovarian cancer	0.000355	0.000565	CcSEcCtD
Bisoprolol—Muscle spasms—Epirubicin—ovarian cancer	0.000354	0.000563	CcSEcCtD
Bisoprolol—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000352	0.000561	CcSEcCtD
Bisoprolol—Body temperature increased—Docetaxel—ovarian cancer	0.000352	0.00056	CcSEcCtD
Bisoprolol—Abdominal pain—Docetaxel—ovarian cancer	0.000352	0.00056	CcSEcCtD
Bisoprolol—Arrhythmia—Doxorubicin—ovarian cancer	0.000349	0.000556	CcSEcCtD
Bisoprolol—Dizziness—Paclitaxel—ovarian cancer	0.000347	0.000553	CcSEcCtD
Bisoprolol—Alopecia—Doxorubicin—ovarian cancer	0.000345	0.00055	CcSEcCtD
Bisoprolol—Mental disorder—Doxorubicin—ovarian cancer	0.000342	0.000545	CcSEcCtD
Bisoprolol—Ill-defined disorder—Epirubicin—ovarian cancer	0.000341	0.000543	CcSEcCtD
Bisoprolol—Erythema—Doxorubicin—ovarian cancer	0.00034	0.000542	CcSEcCtD
Bisoprolol—Agitation—Epirubicin—ovarian cancer	0.000338	0.000538	CcSEcCtD
Bisoprolol—Vomiting—Paclitaxel—ovarian cancer	0.000334	0.000532	CcSEcCtD
Bisoprolol—Dysgeusia—Doxorubicin—ovarian cancer	0.000333	0.000531	CcSEcCtD
Bisoprolol—Malaise—Epirubicin—ovarian cancer	0.000332	0.000528	CcSEcCtD
Bisoprolol—Rash—Paclitaxel—ovarian cancer	0.000331	0.000527	CcSEcCtD
Bisoprolol—Dermatitis—Paclitaxel—ovarian cancer	0.000331	0.000527	CcSEcCtD
Bisoprolol—Vertigo—Epirubicin—ovarian cancer	0.00033	0.000526	CcSEcCtD
Bisoprolol—Syncope—Epirubicin—ovarian cancer	0.00033	0.000525	CcSEcCtD
Bisoprolol—Back pain—Doxorubicin—ovarian cancer	0.000329	0.000524	CcSEcCtD
Bisoprolol—Headache—Paclitaxel—ovarian cancer	0.000329	0.000524	CcSEcCtD
Bisoprolol—Hypersensitivity—Docetaxel—ovarian cancer	0.000328	0.000522	CcSEcCtD
Bisoprolol—Muscle spasms—Doxorubicin—ovarian cancer	0.000327	0.000521	CcSEcCtD
Bisoprolol—Palpitations—Epirubicin—ovarian cancer	0.000325	0.000518	CcSEcCtD
Bisoprolol—Loss of consciousness—Epirubicin—ovarian cancer	0.000323	0.000515	CcSEcCtD
Bisoprolol—Cough—Epirubicin—ovarian cancer	0.000321	0.000511	CcSEcCtD
Bisoprolol—Asthenia—Docetaxel—ovarian cancer	0.000319	0.000508	CcSEcCtD
Bisoprolol—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000316	0.000503	CcSEcCtD
Bisoprolol—Pruritus—Docetaxel—ovarian cancer	0.000315	0.000501	CcSEcCtD
Bisoprolol—Arthralgia—Epirubicin—ovarian cancer	0.000313	0.000499	CcSEcCtD
Bisoprolol—Chest pain—Epirubicin—ovarian cancer	0.000313	0.000499	CcSEcCtD
Bisoprolol—Myalgia—Epirubicin—ovarian cancer	0.000313	0.000499	CcSEcCtD
Bisoprolol—Agitation—Doxorubicin—ovarian cancer	0.000313	0.000498	CcSEcCtD
Bisoprolol—Anxiety—Epirubicin—ovarian cancer	0.000312	0.000497	CcSEcCtD
Bisoprolol—Nausea—Paclitaxel—ovarian cancer	0.000312	0.000497	CcSEcCtD
Bisoprolol—Propranolol—ABCB1—ovarian cancer	0.000312	0.127	CrCbGaD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000311	0.000495	CcSEcCtD
Bisoprolol—Discomfort—Epirubicin—ovarian cancer	0.000309	0.000493	CcSEcCtD
Bisoprolol—Malaise—Doxorubicin—ovarian cancer	0.000307	0.000489	CcSEcCtD
Bisoprolol—Dry mouth—Epirubicin—ovarian cancer	0.000306	0.000488	CcSEcCtD
Bisoprolol—Vertigo—Doxorubicin—ovarian cancer	0.000306	0.000487	CcSEcCtD
Bisoprolol—Syncope—Doxorubicin—ovarian cancer	0.000305	0.000486	CcSEcCtD
Bisoprolol—Diarrhoea—Docetaxel—ovarian cancer	0.000304	0.000485	CcSEcCtD
Bisoprolol—Confusional state—Epirubicin—ovarian cancer	0.000303	0.000482	CcSEcCtD
Bisoprolol—Palpitations—Doxorubicin—ovarian cancer	0.000301	0.000479	CcSEcCtD
Bisoprolol—Oedema—Epirubicin—ovarian cancer	0.0003	0.000478	CcSEcCtD
Bisoprolol—Loss of consciousness—Doxorubicin—ovarian cancer	0.000299	0.000476	CcSEcCtD
Bisoprolol—Infection—Epirubicin—ovarian cancer	0.000298	0.000475	CcSEcCtD
Bisoprolol—Cough—Doxorubicin—ovarian cancer	0.000297	0.000473	CcSEcCtD
Bisoprolol—Shock—Epirubicin—ovarian cancer	0.000295	0.00047	CcSEcCtD
Bisoprolol—Nervous system disorder—Epirubicin—ovarian cancer	0.000294	0.000469	CcSEcCtD
Bisoprolol—Dizziness—Docetaxel—ovarian cancer	0.000294	0.000469	CcSEcCtD
Bisoprolol—Thrombocytopenia—Epirubicin—ovarian cancer	0.000294	0.000468	CcSEcCtD
Bisoprolol—Tachycardia—Epirubicin—ovarian cancer	0.000293	0.000467	CcSEcCtD
Bisoprolol—Skin disorder—Epirubicin—ovarian cancer	0.000292	0.000464	CcSEcCtD
Bisoprolol—Hyperhidrosis—Epirubicin—ovarian cancer	0.00029	0.000462	CcSEcCtD
Bisoprolol—Myalgia—Doxorubicin—ovarian cancer	0.00029	0.000461	CcSEcCtD
Bisoprolol—Arthralgia—Doxorubicin—ovarian cancer	0.00029	0.000461	CcSEcCtD
Bisoprolol—Chest pain—Doxorubicin—ovarian cancer	0.00029	0.000461	CcSEcCtD
Bisoprolol—Anxiety—Doxorubicin—ovarian cancer	0.000289	0.00046	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000288	0.000458	CcSEcCtD
Bisoprolol—Discomfort—Doxorubicin—ovarian cancer	0.000286	0.000456	CcSEcCtD
Bisoprolol—Dry mouth—Doxorubicin—ovarian cancer	0.000283	0.000451	CcSEcCtD
Bisoprolol—Vomiting—Docetaxel—ovarian cancer	0.000283	0.000451	CcSEcCtD
Bisoprolol—Rash—Docetaxel—ovarian cancer	0.000281	0.000447	CcSEcCtD
Bisoprolol—Hypotension—Epirubicin—ovarian cancer	0.00028	0.000447	CcSEcCtD
Bisoprolol—Dermatitis—Docetaxel—ovarian cancer	0.00028	0.000446	CcSEcCtD
Bisoprolol—Confusional state—Doxorubicin—ovarian cancer	0.00028	0.000446	CcSEcCtD
Bisoprolol—Headache—Docetaxel—ovarian cancer	0.000279	0.000444	CcSEcCtD
Bisoprolol—Oedema—Doxorubicin—ovarian cancer	0.000278	0.000442	CcSEcCtD
Bisoprolol—Infection—Doxorubicin—ovarian cancer	0.000276	0.000439	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000273	0.000435	CcSEcCtD
Bisoprolol—Shock—Doxorubicin—ovarian cancer	0.000273	0.000435	CcSEcCtD
Bisoprolol—Nervous system disorder—Doxorubicin—ovarian cancer	0.000272	0.000434	CcSEcCtD
Bisoprolol—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000272	0.000433	CcSEcCtD
Bisoprolol—Insomnia—Epirubicin—ovarian cancer	0.000271	0.000432	CcSEcCtD
Bisoprolol—Tachycardia—Doxorubicin—ovarian cancer	0.000271	0.000432	CcSEcCtD
Bisoprolol—Skin disorder—Doxorubicin—ovarian cancer	0.00027	0.00043	CcSEcCtD
Bisoprolol—Paraesthesia—Epirubicin—ovarian cancer	0.000269	0.000429	CcSEcCtD
Bisoprolol—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000268	0.000428	CcSEcCtD
Bisoprolol—Dyspnoea—Epirubicin—ovarian cancer	0.000268	0.000426	CcSEcCtD
Bisoprolol—Somnolence—Epirubicin—ovarian cancer	0.000267	0.000425	CcSEcCtD
Bisoprolol—Nausea—Docetaxel—ovarian cancer	0.000264	0.000421	CcSEcCtD
Bisoprolol—Dyspepsia—Epirubicin—ovarian cancer	0.000264	0.000421	CcSEcCtD
Bisoprolol—Hypotension—Doxorubicin—ovarian cancer	0.000259	0.000413	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000259	0.000413	CcSEcCtD
Bisoprolol—Fatigue—Epirubicin—ovarian cancer	0.000259	0.000412	CcSEcCtD
Bisoprolol—Constipation—Epirubicin—ovarian cancer	0.000257	0.000409	CcSEcCtD
Bisoprolol—Pain—Epirubicin—ovarian cancer	0.000257	0.000409	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000253	0.000403	CcSEcCtD
Bisoprolol—Insomnia—Doxorubicin—ovarian cancer	0.000251	0.0004	CcSEcCtD
Bisoprolol—Paraesthesia—Doxorubicin—ovarian cancer	0.000249	0.000397	CcSEcCtD
Bisoprolol—Dyspnoea—Doxorubicin—ovarian cancer	0.000248	0.000394	CcSEcCtD
Bisoprolol—Feeling abnormal—Epirubicin—ovarian cancer	0.000247	0.000394	CcSEcCtD
Bisoprolol—Somnolence—Doxorubicin—ovarian cancer	0.000247	0.000393	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000245	0.000391	CcSEcCtD
Bisoprolol—Dyspepsia—Doxorubicin—ovarian cancer	0.000244	0.000389	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00024	0.000382	CcSEcCtD
Bisoprolol—Fatigue—Doxorubicin—ovarian cancer	0.000239	0.000381	CcSEcCtD
Bisoprolol—Urticaria—Epirubicin—ovarian cancer	0.000238	0.00038	CcSEcCtD
Bisoprolol—Constipation—Doxorubicin—ovarian cancer	0.000237	0.000378	CcSEcCtD
Bisoprolol—Pain—Doxorubicin—ovarian cancer	0.000237	0.000378	CcSEcCtD
Bisoprolol—Abdominal pain—Epirubicin—ovarian cancer	0.000237	0.000378	CcSEcCtD
Bisoprolol—Body temperature increased—Epirubicin—ovarian cancer	0.000237	0.000378	CcSEcCtD
Bisoprolol—Feeling abnormal—Doxorubicin—ovarian cancer	0.000229	0.000364	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000227	0.000362	CcSEcCtD
Bisoprolol—Hypersensitivity—Epirubicin—ovarian cancer	0.000221	0.000352	CcSEcCtD
Bisoprolol—Urticaria—Doxorubicin—ovarian cancer	0.000221	0.000351	CcSEcCtD
Bisoprolol—Body temperature increased—Doxorubicin—ovarian cancer	0.00022	0.00035	CcSEcCtD
Bisoprolol—Abdominal pain—Doxorubicin—ovarian cancer	0.00022	0.00035	CcSEcCtD
Bisoprolol—Asthenia—Epirubicin—ovarian cancer	0.000215	0.000343	CcSEcCtD
Bisoprolol—Pruritus—Epirubicin—ovarian cancer	0.000212	0.000338	CcSEcCtD
Bisoprolol—Diarrhoea—Epirubicin—ovarian cancer	0.000205	0.000327	CcSEcCtD
Bisoprolol—Hypersensitivity—Doxorubicin—ovarian cancer	0.000205	0.000326	CcSEcCtD
Bisoprolol—Asthenia—Doxorubicin—ovarian cancer	0.000199	0.000317	CcSEcCtD
Bisoprolol—Dizziness—Epirubicin—ovarian cancer	0.000198	0.000316	CcSEcCtD
Bisoprolol—Pruritus—Doxorubicin—ovarian cancer	0.000196	0.000313	CcSEcCtD
Bisoprolol—Vomiting—Epirubicin—ovarian cancer	0.000191	0.000304	CcSEcCtD
Bisoprolol—Diarrhoea—Doxorubicin—ovarian cancer	0.00019	0.000303	CcSEcCtD
Bisoprolol—Rash—Epirubicin—ovarian cancer	0.000189	0.000301	CcSEcCtD
Bisoprolol—Dermatitis—Epirubicin—ovarian cancer	0.000189	0.000301	CcSEcCtD
Bisoprolol—Headache—Epirubicin—ovarian cancer	0.000188	0.000299	CcSEcCtD
Bisoprolol—Dizziness—Doxorubicin—ovarian cancer	0.000184	0.000292	CcSEcCtD
Bisoprolol—Nausea—Epirubicin—ovarian cancer	0.000178	0.000284	CcSEcCtD
Bisoprolol—Vomiting—Doxorubicin—ovarian cancer	0.000177	0.000281	CcSEcCtD
Bisoprolol—Rash—Doxorubicin—ovarian cancer	0.000175	0.000279	CcSEcCtD
Bisoprolol—Dermatitis—Doxorubicin—ovarian cancer	0.000175	0.000279	CcSEcCtD
Bisoprolol—Headache—Doxorubicin—ovarian cancer	0.000174	0.000277	CcSEcCtD
Bisoprolol—Nausea—Doxorubicin—ovarian cancer	0.000165	0.000263	CcSEcCtD
